Dishman Carbogen Amcis cash flow

Latest FY26
Cash from operations
₹491cr+31.0% on FY25
Capital spending
₹266cr+22.7% on FY25
Free cash flow
₹225cr+42.3% on FY25
Cash from financing
₹201cr−₹102 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—339294311281
—0.0−7.50.00.0
—−61.62.4−6.347.3
—−22.418.7−30.2−48.6
Changes in working capital
—−123−24.5−85.2−159
—29.2−181123−120
—−38.8−2.617.532.5
—11312888.1208
Cash from operating activities
15.010519.3−122−54.6
—236227418242
—341246296187
—−18.50.0−13.0−18.3
—−174−159−120−85.7
—5.030.319.034.2
—491375384220
Cash from investing activities
—266217303574
—−0.61.30.11.5
—0.00.0−150−116
—0.00.00.012.3
—0.145.80.0−0.3
—9.32.212.115.6
—11.9−24.7−88.45.3
—−245−192−230−448
Cash from financing activities
—782283148332
—37620429.0−22.7
—50.029.942.832.0
—15615198.673.3
—201−102−22.2250
—44780.913221.6
—0.0−4.01320.0
—44777.026421.6
———264132
Reference items
485566469287332
16.7%19.3%17.3%11.0%13.8%
22522515880.7−354
—761127122—
₹14.38₹14.38₹10.11₹5.15−₹22.56
10.35×————
—5.04×115.81×−2.50×−7.39×
—5.030.319.034.2
—15615198.673.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

DCAL₹148.86

Dishman Carbogen Amcis Limited

· Pharma & Health
₹ CrorePeersHIKALSOLARAPANACEABIOINDSWFTLABSAIPARENTINDOCOSMSPHARMAWINDLASMcap ₹2,334 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation280.7310.9293.7338.7—
+ Interest Income0.00.0-7.50.0—
+ Unrealised FX (Gain) / Loss47.3-6.32.4-61.6—
+ Other Non-cash Items-48.6-30.218.7-22.4—
Changes in Working Capital
+ Inventories-158.7-85.2-24.5-122.7—
+ Trade Receivables — Current-119.6123.5-181.129.2—
+ Other Current Assets32.517.5-2.6-38.8—
+ Trade Payables — Current208.188.1127.6113.4—
Cash from Operating Activities
Profit Before Tax (per I/S)-54.6-122.319.3104.915.0
+ Total Adjustments (incl. Working Capital)241.7418.2226.8235.9—
Cash from Operations (pre-tax)187.1296.0246.1340.8—
+ Interest Received — Operating-18.3-13.00.0-18.5—
+ Interest Paid — Operating-85.7-120.0-159.5-174.2—
+ Income Taxes Paid34.219.030.35.0—
Cash from Operating Activities220.3384.0375.2491.5—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)574.1303.3216.8266.0—
+ Disp of Fixed Assets1.50.11.3-0.6—
+ Purchase of Investments (Equity / Debt)-115.9-149.90.00.0—
+ Acq of Subsidiaries / Businesses (net)12.30.00.00.0—
+ Loans & Advances Repaid-0.30.045.80.1—
+ Interest Received — Investing15.612.12.29.3—
+ Other Inflows / (Outflows) — Investing5.3-88.4-24.711.9—
Cash from Investing Activities-448.5-229.5-192.2-245.3—
Cash from Financing Activities
+ Proceeds from Borrowings332.2148.2283.1782.5—
+ Repayment of Borrowings-22.729.0204.3375.8—
+ Payment of Lease Liabilities32.042.829.950.0—
+ Interest Paid73.398.6151.0156.1—
Cash from Financing Activities249.7-22.2-102.1200.6—
Net Changes in Cash (pre-FX)21.6132.380.9446.7—
+ Effect of FX Rate Changes on Cash0.0131.8-4.00.0—
Net Changes in Cash21.6264.177.0446.7—
Closing Cash131.8264.1———
Reference Items
EBITDA332.2286.5468.9565.6485.0
EBITDA Margin %13.7710.9517.2919.2916.72
Free Cash Flow (CFO − Capex)-353.780.7158.5225.5225.5
Free Cash Flow to Equity—122.0127.0760.9—
Free Cash Flow per Basic Share-22.565.1510.1114.3814.38
Price to Free Cash Flow————10.35
Cash Flow to Net Income-7.39-2.50115.815.04—
Cash Paid for Taxes34.219.030.35.0—
Cash Paid for Interest73.398.6151.0156.1—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.